Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Sees Significant Growth in Short Interest

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the target of a large growth in short interest in the month of September. As of September 30th, there was short interest totaling 1,948 shares, a growth of 126.2% from the September 15th total of 861 shares. Based on an average trading volume of 8,598 shares, the short-interest ratio is presently 0.2 days.

Carl Zeiss Meditec Price Performance

Shares of OTCMKTS:CZMWY traded down $0.02 during mid-day trading on Wednesday, reaching $36.70. The stock had a trading volume of 3,193 shares, compared to its average volume of 4,144. Carl Zeiss Meditec has a 1 year low of $26.65 and a 1 year high of $55.94. The business’s 50 day moving average price is $35.77 and its 200 day moving average price is $32.70.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on CZMWY shares. UBS Group cut shares of Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a report on Tuesday, August 11th. The Goldman Sachs Group cut shares of Carl Zeiss Meditec from a “hold” rating to a “sell” rating in a research note on Monday, October 5th. Zacks Research raised Carl Zeiss Meditec from a “strong sell” rating to a “hold” rating in a report on Tuesday, October 6th. Finally, Morgan Stanley started coverage on Carl Zeiss Meditec in a research report on Wednesday, September 2nd. They issued an “underweight” rating for the company. Two analysts have rated the stock with a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Strong Sell”.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG is a Germany-based medical technology company focused on ophthalmology and microsurgery. The company develops and manufactures equipment, systems and related solutions used by physicians and hospitals for diagnosing and treating eye conditions, as well as for other surgical procedures.

Its ophthalmic portfolio includes diagnostic and imaging systems, laser systems for refractive and cataract surgery, surgical microscopes, visualization technologies and intraocular lenses.